Steve Meyers plans sale of 4,408 common shares

Form 144 shows that Steve Meyers has filed a notice of intent to sell 4,408 shares of common stock through Morgan Stanley Smith Barney on the NASDAQ, with an approximate aggregate market value of $37,636.39.

Rhea-AI Filing Summary

Form 144 shows that Steve Meyers has filed a notice of intent to sell 4,408 shares of common stock through Morgan Stanley Smith Barney on the NASDAQ, with an approximate aggregate market value of $37,636.39. The issuer has 213,047,472 shares outstanding.

The shares to be sold come from restricted stock vesting under a registered plan on 02/03/2026, acquired directly from the issuer. In the prior three months, Meyers sold 3,052 common shares for $27,903.83. The filer represents they know no undisclosed material adverse information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for OCUL disclose about planned share sales?

The filing shows Steve Meyers plans to sell 4,408 common shares of OCUL through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $37,636.39. This is a notice of proposed sales under Rule 144, not a confirmation of completion.

How many OCUL shares are outstanding in the Form 144 notice?

The Form 144 states that the issuer has 213,047,472 common shares outstanding. This figure provides context for the planned sale of 4,408 shares, indicating the notice relates to a very small portion of the company’s total outstanding stock at the time referenced.

How were the OCUL shares in the Form 144 acquired by the seller?

The filing explains the 4,408 OCUL common shares were acquired on 02/03/2026 as restricted stock vesting under a registered plan from the issuer. The nature of payment is listed as “Not Applicable,” reflecting that this was an equity award vesting rather than a cash purchase.

What prior OCUL share sales are disclosed in the last three months?

The Form 144 reports that Steve Meyers previously sold 3,052 OCUL common shares on 02/02/2026, generating $27,903.83 in gross proceeds. This historical sale information is required to be aggregated with the new planned sale under Rule 144 reporting rules.

Which broker and exchange are involved in the OCUL Form 144 sale?

The notice lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, as the broker handling the proposed sale of 4,408 OCUL common shares. The securities are planned to be sold on the NASDAQ stock market, according to the filing.

What representation does the seller make in the OCUL Form 144 filing?

By signing the notice, the seller represents they do not know any material adverse information about OCUL’s current or prospective operations that has not been publicly disclosed. This representation is a standard requirement when filing planned sales under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/04/2026 - 04:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002073994
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OCULAR THERAPEUTIX, INC.
SEC File Number	001-36554
Address of Issuer	15 Crosby Drive Bedford MASSACHUSETTS 01730
Phone	781-357-4000
Name of Person for Whose Account the Securities are To Be Sold	STEVE MEYERS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4408	37636.39	213047472	02/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/03/2026	Restricted stock vesting under a registered plan	Issuer			4408	02/03/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
STEVE MEYERS 15 Crosby Drive Bedford MA 01730	Common	02/02/2026	3052	27903.83

144: Remarks and Signature

Remarks
Date of Notice	02/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Steve Meyers
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)